1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Cavo, M., Gay, F., Beksac, M., Pantani, L., Petrucci, M. T., Dimopoulos, M. A., Dozza, L., van der Holt, B., Zweegman, S., Oliva, S., van der Velden, V. H. J., Zamagni, E., Palumbo, G. A., Patriarca, F., Montefusco, V., Galli, M., Maisnar, V., Gamberi, B., Hansson, M., Belotti, A. & 39 others, Pour, L., Ypma, P., Grasso, M., Croockewit, A., Ballanti, S., Offidani, M., Vincelli, I. D., Zambello, R., Liberati, A. M., Andersen, N. F., Broijl, A., Troia, R., Pascarella, A., Benevolo, G., Levin, M. D., Bos, G., Ludwig, H., Aquino, S., Morelli, A. M., Wu, K. L., Boersma, R., Hajek, R., Durian, M., von dem Borne, P. A., Caravita di Toritto, T., Driessen, C., Specchia, G., Waage, A., Gimsing, P., Mellqvist, U. H., van Marwijk Kooy, M., Minnema, M., Mandigers, C., Cafro, A. M., Palmas, A., Carvalho, S., Spencer, A., Boccadoro, M. & Sonneveld, P., 1 Jan 2020, (Accepted/In press) In : The Lancet Haematology. 7, 6

Research output: Contribution to journalArticleAcademicpeer-review

Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome

Boiten, H. J., Buijze, M., Zweegman, S. & Levin, M. D., 1 Jan 2020, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab

Frerichs, K. A., Broekmans, M. E. C., Marin Soto, J. A., van Kessel, B., Heymans, M. W., Holthof, L. C., Verkleij, C. P. M., Boominathan, R., Vaidya, B., Sendecki, J., Axel, A., Gaudet, F., Pillarisetti, K., Zweegman, S., Adams, H. C., Mutis, T. & van de Donk, N. W. C. J., 1 May 2020, In : Clinical cancer research : an official journal of the American Association for Cancer Research. 26, 9, p. 2203-2215 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

Holthof, L. C., van der Horst, H. J., van Hal-van Veen, S. E., Ruiter, R. W. J., Li, F., Buijze, M., Andersen, M. N., Yuan, H., de Bruijn, J., van de Donk, N. W. C. J., Lokhorst, H. M., Zweegman, S., Groen, R. W. J. & Mutis, T., 1 Jan 2020, In : Haematologica. 105, 2, p. e80-e83

Research output: Contribution to journalLetterAcademicpeer-review

Open Access